Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.18 USD | -1.12% | +8.78% | +25.46% |
05-17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |